Search Results - Scott Rodig
- Showing 1 - 13 results of 13
-
1
Anti-CTLA-4 based therapy elicits humoral immunity to galectin-3 in patients with metastatic melanoma by Xinqi Wu, Anita Giobbie-Hurder, Erin M. Connolly, Jingjing Li, Xiaoyun Liao, Mariano Severgnini, Jun Zhou, Scott Rodig, F. Stephen Hodi
Published in OncoImmunology (2018-07-01)Get full text
Article -
2
67 Cancer aneuploidy is associated with a distinct tumor immune microenvironment and impacts outcomes to immune checkpoint inhibition in nonsquamous non-small cell lung cancer by Mark Awad, Gonzalo Recondo, Giuseppe Lamberti, Scott Rodig, Joao Victor Alessi, Victor Vaz, Adriana Barrichello, Yvonne Lin-Liu, Hersh Gupta, Xinan Wang, Andrew Cherniack, Kristen Felt
Published in Journal for ImmunoTherapy of Cancer (2021-11-01)Article -
3
Phase IB study of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors by Howard Streicher, Elad Sharon, Mariano Severgnini, Michael Manos, Anita Giobbie-Hurder, F Stephen Hodi, Andrew S Brohl, Philippe L Bedard, Kevin Tyan, Scott Rodig, Osama E Rahma, Daniel J Renouf, Emma Hathaway, Rachel Cunningham
Published in Journal for ImmunoTherapy of Cancer (2022-03-01)Get full text
Article -
4
T028: Single-cell RNA sequencing reveals the interplay between circulating CD4 T cells, B cells and cancer-associated monocytes in classic Hodgkin lymphoma treated with PD-1 blocka... by Julia Paczkowska, Ming Tang, Kyle T. Wright, Li Song, Vignesh Shanmugam, Kelsey Luu, Emma L. Welsh, Fathima Zumla Cader, Elisa Mandato, Jing Ouyang, Gali Bai, Lee Lawton, Scott Rodig, X Shirley Liu, Margaret A. Shipp
Published in HemaSphere (2022-10-01)Get full text
Article -
5
SlideCNA: spatial copy number alteration detection from Slide-seq-like spatial transcriptomics data by Diane Zhang, Åsa Segerstolpe, Michal Slyper, Julia Waldman, Evan Murray, Robert Strasser, Jan Watter, Ofir Cohen, Orr Ashenberg, Daniel Abravanel, Judit Jané-Valbuena, Simon Mages, Ana Lako, Karla Helvie, Orit Rozenblatt-Rosen, Scott Rodig, Fei Chen, Nikhil Wagle, Aviv Regev, Johanna Klughammer
Published in Genome Biology (2025-05-01)Get full text
Article -
6
Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors by Vignesh Shanmugam, Neriman Tokcan, Daniel Chafamo, Sean Sullivan, Mehdi Borji, Haley Martin, Gail Newton, Naeem Nadaf, Saoirse Hanbury, Irving Barrera, Dylan Cable, Jackson Weir, Orr Ashenberg, Geraldine Pinkus, Scott Rodig, Caroline Uhler, Evan Macosko, Margaret Shipp, Abner Louissaint, Fei Chen, Todd R. Golub
Published in Nature Communications (2025-12-01)Get full text
Article -
7
Author Correction: Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors by Vignesh Shanmugam, Neriman Tokcan, Daniel Chafamo, Sean Sullivan, Mehdi Borji, Haley Martin, Gail Newton, Naeem Nadaf, Saoirse Hanbury, Irving Barrera, Dylan Cable, Jackson Weir, Orr Ashenberg, Geraldine Pinkus, Scott Rodig, Caroline Uhler, Evan Macosko, Margaret Shipp, Abner Louissaint, Fei Chen, Todd R. Golub
Published in Nature Communications (2026-05-01)Get full text
Article -
8
Identification of ALK gene alterations in urothelial carcinoma. by Joaquim Bellmunt, Shamini Selvarajah, Scott Rodig, Marta Salido, Silvia de Muga, Irmgard Costa, Beatriz Bellosillo, Lillian Werner, Stephanie Mullane, André P Fay, Robert O'Brien, Jordi Barretina, André E Minoche, Sabina Signoretti, Clara Montagut, Heinz Himmelbauer, David M Berman, Philip Kantoff, Toni K Choueiri, Jonathan E Rosenberg
Published in PLoS ONE (2014-01-01)Get full text
Article -
9
Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic... by Craig L Slingluff, Gina R Petroni, Todd Bauer, Nipun Merchant, Osama Rahma, Rawad Elias, Scott Rodig, Matthew H G Katz, Andressa Dias Costa, Brian M Wolpin, Stephanie K Dougan, Chee-Chee Stucky, Kathleen Pfaff, Gauri R Varadhachary, Victoire Cardot-Ruffino, Matthew J Reilley, Patrick Lenehan, Tanios S Bekaii-Saab, Jonathan Andrew Nowak
Published in Journal for ImmunoTherapy of Cancer (2023-12-01)Get full text
Article -
10
700 Increasing MHC-I expression to potentiate immune checkpoint blockade therapy by Peng Jiang, Xia Bu, Michael Manos, Ana Lako, Scott Rodig, Yingtian Xie, Shengqing Gu, Henry Long, Paloma Cejas, Gordon Freeman, Wubing Zhang, Xiaoqing Wang, Nicole Traugh, Ziyi Li, Clifford Meyer, Blair Stewig, Alba Font-Tello, Klothilda Lim, Jake Conway, Alok Tewari, Zexian Zeng, Avinash Das Sahu, Collin Tokheim, Jason Weirather, Jingxin Fu, Benjamin Kroger, Jin Hua Liang, Benjamin Gewurz, F. Stephen Hodi, Myles Brown, X Shirley Liu
Published in Journal for ImmunoTherapy of Cancer (2021-11-01)Article -
11
Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry. by Michael J Kluk, Todd Ashworth, Hongfang Wang, Birgit Knoechel, Emily F Mason, Elizabeth A Morgan, David Dorfman, Geraldine Pinkus, Oliver Weigert, Jason L Hornick, Lucian R Chirieac, Michelle Hirsch, David J Oh, Andrew P South, Irene M Leigh, Celine Pourreyron, Andrew J Cassidy, Daniel J Deangelo, David M Weinstock, Ian E Krop, Deborah Dillon, Jane E Brock, Alexander J F Lazar, Myron Peto, Raymond J Cho, Alexander Stoeck, Brian B Haines, Sriram Sathayanrayanan, Scott Rodig, Jon C Aster
Published in PLoS ONE (2013-01-01)Get full text
Article -
12
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders by Jeffrey A Meyerhardt, Sunil Kumar, Jessica A Zerillo, Aparna Parikh, James M Cleary, Scott Rodig, Benjamin Schlechter, Kimmie Ng, Stephanie K Dougan, Nora Horick, Glenn J Hanna, Andrew L Coveler, Anuj K Patel, Nadine J McCleary, Douglas A Rubinson, Jeffrey W Clark, Kent Mouw, Kathleen Pfaff, Thomas A Abrams, Matthew B Yurgelun, Eliezer M Van Allen, S Jennifer Wang, Leah H Biller, Harshabad Singh, Emma L Welsh, Brandon M Huffman, Lestat R Ali, Megan T Hoffman, Katherine A Metayer, Shayla Murray, Alexandra Bird, Jennifer A Chan, Wolfram Goessling, Jeffrey S Wisch, Brendan Reardon, Robert J Mayer, Catherine Del Vecchio Fitz, Charlotte Kuperwasser
Published in Journal for ImmunoTherapy of Cancer (2024-01-01)Get full text
Article -
13
Three-Year Overall Survival Outcomes and Correlative Analyses in Patients With NSCLC and High (50%–89%) Versus Very High (≥90%) Programmed Death-Ligand 1 Expression Treated With Fi... by Biagio Ricciuti, MD, PhD, Arielle Elkrief, MD, Jessica Lin, MD, Jianjun Zhang, MD, Joao V. Alessi, MD, Giuseppe Lamberti, MD, PhD, Malini Gandhi, MD, Alessandro Di Federico, MD, Federica Pecci, MD, Xinan Wang, PhD, Maisam Makarem, MD, PhD, Cassio Murilo Hidalgo Filho, MD, Teresa Gorria, MD, Arushi Saini, BS, Cindy Pabon, MD, James Lindsay, PhD, Kathleen L. Pfaff, PhD, Emma L. Welsh, BS, Mizuki Nishino, MD, Lynette M. Sholl, MD, Scott Rodig, MD, Saadettin Kilickap, MD, Petra Rietschel, MD, Debra AG. McIntyre, PhD, Jean-Francois Pouliot, MD, Mehmet Altan, MD, Justin F. Gainor, MD, John V. Heymach, MD, Adam J. Schoenfeld, MD, Mark M. Awad, MD, PhD
Published in JTO Clinical and Research Reports (2024-09-01)Get full text
Article
